BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
3.680
+0.130 (3.66%)
Jun 26, 2026, 4:00 PM EDT - Market closed
BioAtla Employees
BioAtla had 41 employees as of December 31, 2025. The number of employees decreased by 20 or -32.79% compared to the previous year.
Employees
41
Change (1Y)
-20
Growth (1Y)
-32.79%
Revenue / Employee
$48,780
Profits / Employee
-$1,234,561
Market Cap
6.11M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| NextCure | 40 |
| Cardio Diagnostics Holdings | 17 |
| Soligenix | 14 |
| NuCana | 12 |
| Purple Biotech | 10 |
| Can-Fite BioPharma | 5 |
| Acurx Pharmaceuticals | 4 |
| Silo Pharma | 3 |
BCAB News
- 24 days ago - BioAtla Proxy statement: Proxy filing - Filings
- 24 days ago - BioAtla Proxy statement: Proxy filing - Filings
- 5 weeks ago - Context Therapeutics enters license agreement amendment with BioAtla - TheFly
- 6 weeks ago - BioAtla Quarterly report: Q1 2026 - Filings
- 3 months ago - BioAtla trading halted, news pending - TheFly
- 3 months ago - BioAtla announces 50-for-1 share consolidation - TheFly
- 3 months ago - BioAtla Announces Share Consolidation - GlobeNewsWire
- 3 months ago - BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - GlobeNewsWire